Phase I dose escalation study of the protein kinase C iota inhibitor aurothiomalate for advanced non-small cell lung cancer, ovarian cancer, and pancreatic cancer.
Aaron Scott Mansfield
No relevant relationships to disclose
Alan P. Fields
No relevant relationships to disclose
Aminah Jatoi
No relevant relationships to disclose
Yingwei Qi
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose
Charles Erlichman
No relevant relationships to disclose
Julian R. Molina
No relevant relationships to disclose